Agenus宣布最高達3.4億美元的超額認購私募募資，以推進針對MSS結腸癌新輔助治療方案BOT+BAL的ROBBIN註冊性臨床試驗
businesswire.com
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in